Newcells Head to Boston

International Trade Mission  December 2018 

Newcells Biotech CEO, Dr Mike Nicholds, and CSO, Prof Lyle Armstrong, are delighted to be taking part in a global trade mission hosted by the Department for International Trade and partially funded by the Northern Powerhouse. Dr Nicholds and Prof Armstrong will travel to Greater Boston, which is the home to almost 1,000 drug discovery biotechnology companies, ranging from small start-ups to billion-dollar pharmaceutical companies, all looking to bring new innovative products to market.   

During the trade mission, they will be connecting with representatives from pharmaceutical and biotech companies interested in in-vitro assays for pre-clinical testing of new drugs or collaborating with Newcells on new assay developments. The pair will also be looking to meet with potential US-based partners to expand Newcells Biotech’s reach in North America.  

The mission will focus on the many opportunities Boston has to offer, while taking a closer look at: 

  • Boston’s thriving information technology, education, life sciences, energy and research & development mega-hub 
  • Industry and innovation leaders 
  • Investment opportunities and strategic partnerships
     

If you are interested in the work Newcells Biotech does and want to arrange a meeting prior to the trade mission,
please contact us on 0333 344 6291.  

 

You might also be interested in…
Blog

ESTIV 2018 International Congress

Congress Round-Up The International Congress on in vitro Toxicology (ESTIV2018) organised by the European Society of Toxicology was held in Berlin this October 2018.  This year marks its 20th meeting, with the general theme of new approach methodologies